Måndag 16 Februari | 02:43:30 Europe / Stockholm

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-02-02 07:28:00

Pila Pharma is moving forward with clinical preparations in obesity, despite the company's latest preclinical studies not showing any clear weight loss. Why are you choosing to go directly to humans instead of repeating the animal trials, and what does the financial sustainability look like? BioStock invited CEO Gustav Gram and CSO Dorte Gram to answer questions.

See the whole interview at biostock.se:
https://biostock.se/en/2026/01/pila-pharma-om-prekliniska-data-och-beslutet-att-ga-vidare-till-klinik/
This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se